Since opening its doors four years ago, the Beijing Stock Exchange has become the launch pad for China's new-generation sci-tech firms.
Among its earliest trailblazers was Beijing Tri-Prime Gene Pharmaceutical Co., which joined the exchange in 2021 and quickly turned capital into capability.
Today, the company stands at the forefront of biotech innovation, powered by a new intelligent production and Research and Development (R&D) base.
"This is our intelligent production and R&D base. Our production capacity is three times what it was. Back then, we had to check the density of our products with the naked eye. Now, we use laser eyes, robotic arms, and AI for quality management," said Tri-Prime Gene Chairman and General Manager Cheng Yongqing while showing reporter around.
The most striking difference from four years ago is the new plant's advanced equipment. This upgrade has established Tri-Prime Gene, a research and development-driven biotech firm, as one of Beijing's first advanced intelligent factories.
Cheng directly credited this transformation to the company's listing on the Beijing Stock Exchange.
"After listing on the Beijing Stock Exchange, we raised a lot of capital, which we invested in our case studies and research. With sufficient funds, the speed and scale of our corporate management and research and development have been greatly enhanced," said Cheng.
In the first half of this year alone, the company re-invested 10.93 percent of its operating income back into research and development.
"Focusing on Beijing's role as a science and innovation center, we have guided capital to flow into fields like technology and green finance. We have also established 10 professional policy research teams in securities, funds, insurance, and banking to respond to the real needs of financial governance," said Song Yi, vice president of the Beijing Financial Court.
As of the end of September this year, 276 companies like Tri-Prime Gene have listed on the Beijing Stock Exchange.
Moving forward, Beijing plans to continue guiding enterprises to leverage the platform effectively, encouraging more high-quality tech firms to go public and fully capitalize on their "home-field advantage."
Beijing Stock Exchange fuels sci-tech growth, innovation
